What is the proper administration of Hydroxychloroquine (Baqsimi)?

Proper Administration of Baqsimi (Glucagon Nasal Powder)

Baqsimi is administered as a single spray into one nostril by pressing the plunger on the device. It should not be inhaled and requires no breathing activation.

Clarification of Medication

It appears there may be confusion in the question. Baqsimi is the brand name for glucagon nasal powder, not hydroxychloroquine. Hydroxychloroquine is an oral medication used primarily for malaria and certain autoimmune conditions.

Correct Administration of Baqsimi

Baqsimi (glucagon nasal powder) is administered as follows:

1. Preparation:

   • Remove the shrink wrap by pulling on the red stripe
   • Open the lid and remove the device from the tube
   • Hold the device between fingers and thumb
   • Do not push the plunger until ready to administer

2. Administration:

   • Insert the tip into one nostril
   • Push the plunger all the way in until the green line is no longer visible
   • The dose is complete when the green line disappears
   • The patient does not need to inhale during administration

3. Post-administration:

   • The patient should be placed in a side-lying position if unconscious
   • Emergency medical services should be called after administration
   • Once the patient responds to treatment, oral carbohydrates should be given

Important Considerations

• Baqsimi is used for emergency treatment of severe hypoglycemia
• It is a ready-to-use device that requires no reconstitution
• It can be administered to unconscious patients
• Each device contains a single dose and cannot be reused
• No inhalation is required for the medication to work

Hydroxychloroquine Administration (If That Was Intended)

If the question was actually about hydroxychloroquine:

• Hydroxychloroquine is administered orally with food or milk to minimize gastrointestinal side effects
• Tablets should not be crushed or divided
• Dosing varies by indication:
  • For malaria prophylaxis: 400 mg once weekly in adults
  • For malaria treatment: Initial dose of 800 mg followed by 400 mg at 6,24, and 48 hours
  • For autoimmune conditions: 200-400 mg daily, often in divided doses

Common Pitfalls to Avoid

• Do not confuse Baqsimi (glucagon) with oral medications
• Do not instruct patients to inhale Baqsimi - it works through absorption in the nasal mucosa
• Do not reuse the Baqsimi device as it delivers only one dose
• Do not delay administration of Baqsimi in emergency hypoglycemia situations

If you need specific information about either medication, please clarify which one you're asking about.